Invasive GBM expresses high levels of NF-κB ligand (RANKL) and activates astrocytes at the periphery of the tumor; reactive astrocytes are stimulated, through NF-κB signaling, to secrete TGF-β that promotes tumor progression [136]. The gene discussed is NFKB1; the disease is neoplasm.